BGM Group Acquires Wonder Dragon to Boost Healthcare Strategy

BGM Group Ltd has announced the acquisition of Wonder Dragon Global Limited to enhance its healthcare strategy by integrating premium Qingzhuan dark tea resources.

BGM Group Ltd has announced the acquisition of Wonder Dragon Global Limited to strengthen its healthcare strategy, announced in a press release. The deal involves BGM Group acquiring 100% of Wonder Dragon's equity by issuing 38,165,290 Class A ordinary shares at $2 per share, valuing the transaction at RMB550 million. Completion is expected in the second quarter of 2025.

Wonder Dragon holds over 3,000 metric tons of premium Qingzhuan dark tea, known for its medicinal and historical value. This acquisition will allow BGM Group to expand its health product portfolio and market reach. The company plans to leverage its AI-powered decision-making platform to optimize tea production and develop new medicinal tea products, such as ginseng and goji berry Qingzhuan dark tea.

BGM Group, based in Chengdu, China, focuses on integrating AI technology, big data analytics, and biopharmaceutical innovations to modernize traditional industries. This acquisition aligns with their strategy to enhance their 'medicine + tea + health' product ecosystem.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Healthcare & Life Sciences AI

AI Brief (X)

More from: Funding

Clio to Acquire vLex for $1 Billion, Expanding AI Legal Technology

Jun 30

Recognize Closes $1.7 Billion Fund for Digital Services Investments

Jun 30

Chang Robotics Fund Deploys Initial Capital to Boost U.S. Manufacturing

Jun 30

Audos Secures $11.5 Million to Empower AI Entrepreneurs

Jun 30

Gensmo Secures $60M to Revolutionize Fashion E-Commerce with AI

Jun 30

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.